FDA PreCheck pilot aims to speed U.S. pharma plant construction and approvals for critical medicines with earlier feedback.

The findings show diligence from the FDA and a need for clinicians to discuss risks, benefits, and unknowns with patients before using drugs with accelerated approval.

The initiative by FDA Commissioner Marty Makary promises ultra-fast reviews for drugs that align with “U.S. national priorities.” It’s at the center of Makary’s stated goal to “cut red tape” and ...

The U.S. Food and Drug Administration (FDA) reportedly delayed reviews of several drugs selected for the Trump administration’s new fast-track approval program, after agency scientists raised concerns ...

Forbes contributors publish independent expert analyses and insights. author of Chained to the Desk in a Hybrid World: A Guide to Balance. This voice experience is generated by AI. Learn more. This ...

According to a community announcement, the expansion is aimed at filling critical health care vacancies across Northern Michigan. More than $60,000 in scholarship support will be available in 2026, ...

South Korea’s plan to fast-track AI doctorates reflects a broader effort to strengthen its research competitiveness. Yet the initiative exposes a deeper structural problem — accelerating degrees ...

The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales. Merck's cholesterol treatment ...

Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...

U.S. Transportation Secretary Sean P. Duffy announced a new pilot program within the Federal Aviation Administration (FAA) to accelerate the deployment of advanced air mobility (AAM) vehicles in the ...